CD276 and neoplasm: The checkpoint molecule CD276 expressed in CSC allows these cells to escape immune vigilance through tumor initiation, progression, and metastasis. Anti-CD276 therapy was able to inhibit tumor growth and metastasis, improving antitumor immunity